Common breast cancer risk variants in the post-COGS era: a comprehensive review

por Maxwell, Kara N, Nathanson, Katherine L
Publicado 2013

Using a Machine Learning Approach to Identify Low-Frequency and Rare FLG Alleles Associated with Remission of Atopic Dermatitis

por Berna, Ronald, Mitra, Nandita, Hoffstad, Ole, Wubbenhorst, Bradley, Nathanson, Katherine L., Margolis, David J.
Publicado 2021

CODEX2: full-spectrum copy number variation detection by high-throughput DNA sequencing

por Jiang, Yuchao, Wang, Rujin, Urrutia, Eugene, Anastopoulos, Ioannis N., Nathanson, Katherine L., Zhang, Nancy R.
Publicado 2018

Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF)

por Fung, Chunkit, Vaughn, David J., Mitra, Nandita, Ciosek, Stephanie L., Vardhanabhuti, Saran, Nathanson, Katherine L., Kanetsky, Peter A.
Publicado 2012

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice

por Nath, Kavindra, Nelson, David S., Putt, Mary E., Leeper, Dennis B., Garman, Bradley, Nathanson, Katherine L., Glickson, Jerry D.
Publicado 2016

Germ-line DICER1 mutations do not make a major contribution to the etiology of familial testicular germ cell tumours

por Sabbaghian, Nelly, Bahubeshi, Amin, Shuen, Andrew Y, Kanetsky, Peter A, Tischkowitz, Marc D, Nathanson, Katherine L, Foulkes, William D
Publicado 2013

Homologous recombination pathway gene variants identified by tumor-only sequencing assays in lung carcinoma patients

por Yoon, Ju-Yoon, Roth, Jacquelyn J., Rushton, Chase A., Morrissette, Jennifer J. D., Nathanson, Katherine L., Cohen, Roger B., Rosenbaum, Jason N.
Publicado 2023

DCIS in BRCA1 and BRCA2 mutation carriers: prevalence, phenotype, and expression of oncodrivers C-MET and HER3

por Yang, Rachel L., Mick, Rosemarie, Lee, Kathreen, Graves, Holly L., Nathanson, Katherine L., Domchek, Susan M., Kelz, Rachel R., Zhang, Paul J., Czerniecki, Brian J.
Publicado 2015

Lower abdominal and pelvic radiation and testicular germ cell tumor risk

por Nead, Kevin T., Mitra, Nandita, Weathers, Benita, Pyle, Louisa, Emechebe, Nnadozie, Pucci, Donna A., Jacobs, Linda A., Vaughn, David J., Nathanson, Katherine L., Kanetsky, Peter A.
Publicado 2020

Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes

por Melchor, Lorenzo, Saucedo-Cuevas, Laura Paula, Muñoz-Repeto, Iván, Rodríguez-Pinilla, Socorro María, Honrado, Emiliano, Campoverde, Alfredo, Palacios, Jose, Nathanson, Katherine L, García, María José, Benítez, Javier
Publicado 2009

Reframing the Biological Basis of Neuroprotection Using Functional Genomics: Differentially Weighted, Time-Dependent Multifactor Pathogenesis of Human Ischemic Brain Damage

por Kofke, William A., Ren, Yue, Augoustides, John G., Li, Hongzhe, Nathanson, Katherine, Siman, Robert, Meng, Qing Cheng, Bu, Weiming, Yandrawatthana, Sukanya, Kositratna, Guy, Kim, Cecilia, Bavaria, Joseph E.
Publicado 2018

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation

por Wattenberg, Max M., Asch, Daniella, Yu, Shun, O’Dwyer, Peter J., Domchek, Susan M., Nathanson, Katherine L., Rosen, Mark A., Beatty, Gregory L., Siegelman, Evan S., Reiss, Kim A.
Publicado 2019

The Anti-Melanoma Activity of Dinaciclib, a Cyclin-Dependent Kinase Inhibitor, Is Dependent on p53 Signaling

por Desai, Brijal M., Villanueva, Jessie, Nguyen, Thierry-Thien K., Lioni, Mercedes, Xiao, Min, Kong, Jun, Krepler, Clemens, Vultur, Adina, Flaherty, Keith T., Nathanson, Katherine L., Smalley, Keiran S. M., Herlyn, Meenhard
Publicado 2013

Expression of Drug Targets in Patients Treated with Sorafenib, Carboplatin and Paclitaxel

por Jilaveanu, Lucia B., Zhao, Fengmin, Zito, Christopher R., Kirkwood, John M., Nathanson, Katherine L., D'Andrea, Kurt, Wilson, Melissa, Rimm, David L., Flaherty, Keith T., Lee, Sandra J., Kluger, Harriet M.
Publicado 2013

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing

por Balmaña, Judith, Digiovanni, Laura, Gaddam, Pragna, Walsh, Michael F., Joseph, Vijai, Stadler, Zsofia K., Nathanson, Katherine L., Garber, Judy E., Couch, Fergus J., Offit, Kenneth, Robson, Mark E., Domchek, Susan M.
Publicado 2016

MicroRNA expression profiling predicts clinical outcome of carboplatin/paclitaxel-based therapy in metastatic melanoma treated on the ECOG-ACRIN trial E2603

por Villaruz, Liza C., Huang, Grace, Romkes, Marjorie, Kirkwood, John M., Buch, Shama C., Nukui, Tomoko, Flaherty, Keith T., Lee, Sandra J., Wilson, Melissa A., Nathanson, Katherine L., Benos, Panayiotis V., Tawbi, Hussein A.
Publicado 2015

Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations

por Jean, Stephanie, Li, Jiaqi, Katsaros, Dionyssios, Wubbenhorst, Bradley, Maxwell, Kara N., Fishbein, Lauren, McLane, Michael W., Benedetto, Chiara, Canuto, Emilie Marion, Mitra, Nandita, Zhang, Lin, Nathanson, Katherine L., Tanyi, Janos L.
Publicado 2016

Tumor Detection Rates in Screening of Individuals with SDHx-related Hereditary Paraganglioma-Pheochromocytoma Syndrome

por Greenberg, Samantha E., Jacobs, Michelle F., Wachtel, Heather, Anson, Amanda, Buchmann, Luke, Cohen, Debbie L., Bonanni, Maria, Bennett, Bonita, Naumer, Anne, Schaefer, Amanda M., Kohlmann, Wendy, Nathanson, Katherine L., Else, Tobias, Fishbein, Lauren
Publicado 2020

Real-world integration of genomic data into the electronic health record: the PennChart Genomics Initiative

por Lau-Min, Kelsey S., Asher, Stephanie Byers, Chen, Jessica, Domchek, Susan M., Feldman, Michael, Joffe, Steven, Landgraf, Jeffrey, Speare, Virginia, Varughese, Lisa A., Tuteja, Sony, VanZandbergen, Christine, Ritchie, Marylyn D., Nathanson, Katherine L.
Publicado 2020

Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2 negative patients with early onset breast cancer

por Maxwell, Kara N., Wubbenhorst, Bradley, D’Andrea, Kurt, Garman, Bradley, Long, Jessica M., Powers, Jacquelyn, Rathbun, Katherine, Stopfer, Jill E., Zhu, Jiajun, Bradbury, Angela R., Simon, Michael S., DeMichele, Angela, Domchek, Susan M., Nathanson, Katherine L.
Publicado 2014